This is the historic Biotech Daily Editorials page.
The new page is at: www.biotechdaily.com.au/editorials/
Biotech Daily reports daily news on the sector and rarely makes a comment. The following issues have been judged as of concern to the entire sector and we have added our voice. Editor David Langsam takes responsibility for the opinion, except for articles cosigned by analyst Marc Sinatra.
Another Year In The Grass - With Shrooms & E
Editorial: Selective Briefings & ASX Listing Rule 15.7
Budget 2021 Special Edition; Comment & Response
A Year In The Grass - Medical Marijuana Review
Budget 2020 Special Edition; Comment & Analysis
Biotech Daily 1st Medical Marijuana Survey
CSIRO, Doherty Distance From 'Tier 1' Sars-Cov-2 Claims
Editorial: Covid-19 Spruikers, Please Stop !
Editorial: Covid-19 Coronavirus Claims
Editorial: The 2019-nCoV Coronavirus (Covid-19)
All The Dope On Medicine, Marijuana, Cannabis & Hemp
BNYM & Substantial Shareholder Notices
Federal Election 2019: Policies & Comment
Budget 2019 Comment & Analysis
Your R&D Tax Incentive Is Not Revenue
Victoria Election 2018 - Biotech Daily Editorial
Editorial: Something Is Rotten In Optiscan
2017 - The Year In Review
- CEO, Chairman, Kamikaze of the YearBiotech Daily 12th Birthday Editorial
Biotech Daily Editorial: Selective Briefings - Oct 11, 2017
Budget 2017: 1st MRFF Funding, Steady As She Goes
- Biotech Daily Editorial Comment2016 - The Year In Review: Money, Malcolm & Medical Marijuana
Ausbiotech, Biotech Daily: 'Don't Cut The 45% R&D Tax Incentive' - Sep 13, 2016
Federal Election 2016: Promises, Evidence And Credibility - Jun 30, 2016
Biotech Daily Policy On Mega-Day-Traders
NHMRC $3.3m For Windfarm Health Impacts
AMA Position, Biotech Daily Comment - Mar 22, 2016Mesoblast, The Nasdaq & Comparative Valuations - Nov 19, 2015
Biotech Daily 10th Birthday Editorial - Nov 6, 2015
PM Turnbull Puts Innovation, Chris Pyne Centre of Agenda - Comment
Benitec - Another Band Fails To Make It Big In The USA - Aug 19, 2015
Victoria State Election And State Biotechnology Policies
Biotech Daily 9th Birthday Editorial
Federal Government 'Action Plan'
Comment: Cochlear, Medicines Australia, Biotech Daily, AusbiotechBRIL Group Senate Innovation Submission:
Set Aside 25% Of $20bn MRFF For CommercializationBiota Sacks More Staff, Closes Australian Operations
- Biotech Daily Comment: A DisgraceFederal Budget 2014 - $20b Research Fund, Details, Comment
Trials, Tribulations and Transparency - Apr 2, 2014
Federal Election 2013 Editorial:
No One Offering A $1bn Phase III Trials FundBiotech Daily's 7th Birthday Editorial
Three Strikes For Two Strikes Board Spill Policy - Oct 16, 2012
Patrys, Citigroup And Hiding Behind Nominee Companies - Feb 15, 2012
Chemgenex, Phylogica Trading & Transparency
- May 20, 2011Disclosure & Transparency - Apr 1, 2011
The Year In Review - Dec 16, 2010
Biotech Daily 5th Birthday Editorial
Federal Election 2010 Editorial:
Nepotism Our Best Hope - Aug 19, 2010Political Changes Ring Uncertainty For Biotech
- Jun 24, 2010The Year In Review - Dec 17, 2009
4th Birthday Editorial - Nov 6, 2009
Commercialisation Australia - 'Radical Media Release,
Fabulous Logo' - Oct 21, 2009ASIC Acquires ASX Powers - Now For Transparency - Aug 24, 2009
Ausbiotech, Aspermont & Independent Journalism - Aug 5, 2009
BRIL Group Proposal For Commonwealth Commercialization Institute July 6, 2009
ASX In Wonderland III: Corporate Regulation - June 25, 2009
Biotechs, The Law & Matters Of Principle
June 18, 2009Fermiscan v Prof James: Who Breaks A Butterfly On A Wheel?
April 28, 2009Why Is There Good News?
Apr 14, 2009Once In An Economic Lifetime Opportunity
Jan 30, 2009Genetic Technologies: Friends Of Mervyn & The Perils Of Owner-Drivers
Submission to the National Innovation Review
May 21, 2008Budget 2008 Editorial
May 14, 2008Opes Prime:Caveat Bloody Emptor
April 4, 2008Conlicts of Interest and Transparency
January 19, 2007Federal Budget 2009 Surprises Sector:
Far More Than Expected